Australia: A new study has found that among people with chronic obstructive pulmonary disease (COPD), beta-blocker therapy ...

Novel, experimental treatment for emphysema may offer promising results for patients looking to breathe easier ...

Investors pull away from Upstream as a twice-yearly dose of verekitug fails to match Tezspire’s efficacy in reducing asthma exacerbations.

Investing.com -- Upstream Bio (NASDAQ:UPB) stock fell 23% after the company reported mixed results from its Phase 2 VALIANT trial of verekitug for severe asthma treatment.

Study to assess safety, efficacy and treatment experience of starting inhaled insulin in youth aged 10 to. DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 09, 2026 (GLOBE NEWSWI ...

By Dr. Priyom Bose, Ph.D. By replacing both breathing and circulatory buffering, a novel artificial lung bought critical time after lung removal, revealed irreversible damage, and made transplantation ...

(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data for Breztri in asthma, as UK retail footfall ...

Stopping long-acting inhalers for chronic obstructive pulmonary disease (COPD) can lead to a sharp rise in flare-ups for ...

Managing mucus from COPD involves strategies that can help loosen mucus and clear it from your airway, such as staying ...

Some healthy habits can help reduce your chances of getting lung infections while living with COPD. Learn more here.

Around 1.4 million people in the UK are diagnosed with COPD, with two million thought to be undiagnosed COPD refers to a group of lung disorders caused by obstruction or narrowing of the airways. COPD ...